Abstract #2189
Longitudinal quantitative MRI Provides Quality Assurance Measures in Patients with Ischemic Stroke Treated with Autologous Bone Marrow Derived Mononuclear Cells.
Muhammad E Haque 1 , Khader M Hasan 2 , Benjamin A Schatz 3 , Sarah M Lund 3 , Farhaan S Vahidy 4 , and Sean I Savitz 4
1
Neurology, Unversity of Texas Health Science
Center at Houston, Houston, TX, United States,
2
Diagnostic
and Interventional Imaging, Unversity of Texas Health
Science Center at Houston, Houston, TX, United States,
3
Unversity
of Texas Health Science Center at Houston, TX, United
States,
4
Neurology,
Unversity of Texas Health Science Center at Houston, TX,
United States
Post stroke cell therapy may offer a promising
regenerative therapy. There is a need to establish
reliable neuroimaging markers to assure safety and help
advance neubiological models. In this study we sought to
present some quality assurance measures by testing the
integrity of white matter fibers in the anterior and
posterior corpus callosum regions post MCA stroke.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
